Cardinal Health Inc (CAH)

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Ticker
CAH
Exchange
NYSE
Sector
Healthcare
Industry
Medical Distribution
Market cap
$64.57B
52-week range
$180.45 - $286.29

Valuation

Share price
$278.32 (close of Nov 18, 2026)
P/E (TTM)
35.90x
Price to book
-22.53x
Price to free cash flow
13.17x
Enterprise value
$68.12B
Book value per share
$-12.35

Price performance

PeriodChange
1 day-0.33%
5 days+0.31%
1 month+9.55%
3 months+18.44%
6 months+39.32%
Year to date+35.44%
1 year+34.47%
3 years+169.19%
5 years+464.20%
10 years+293.27%
All time+20,080.91%

Short interest

As of
Oct 30, 2026
Short % of float
3.28%
Shares short
7.58M
Days to cover
4.19
Change since prior report
-1.32%
Source
FINRA consolidated short interest

Members of Congress who disclosed CAH trades

Marjorie Taylor Greene · Alan Armstrong · Robert Bresnahan

Super investors holding CAH

Ken Griffin (Citadel) · Ray Dalio (Bridgewater Associates) · Mason Hawkins (Southeastern Asset Management) · Lee Ainslie (Maverick Capital LTD) · First Eagle Investment (First Eagle Investment Management, LLC) · Mairs & Power (Mairs & Power Inc)

Profitability and growth

Return on invested capital
34.79%
Return on assets
2.99%
Return on capital employed
19.51%
Gross margin
3.84%
Net margin
0.67%
EBITDA margin
1.40%
Revenue growth
14.23%
Net income growth
9.80%
Free cash flow growth
144.59%

Cash flow and balance sheet

Free cash flow yield (TTM)
7.59%
Current ratio
0.88x
Net debt to EBITDA
0.99x

Latest reported year

Period end
Jun 30, 2026
Fiscal year
2026
Revenue
$254.25B
Cost of revenue
$244.47B
Gross profit
$9.77B
EBITDA
$3.57B
Net income
$1.71B
Earnings per share
$7.27
Interest expense
$348.00M
Shares outstanding
236.00M

Income statement by year

Period endRevenueGross profitNet incomeEPS
2026-06-30$254.25B$9.77B$1.71B$7.27
2025-06-30$222.58B$8.17B$1.56B$6.48
2024-06-30$226.83B$7.41B$852.00M$3.48
2023-06-30$204.98B$6.87B$330.00M$1.27
2022-06-30$181.33B$6.48B-$938.00M-$3.37
2021-06-30$162.47B$6.78B$611.00M$2.09
2020-06-30$152.92B$6.87B-$3.70B-$12.61
2019-06-30$145.53B$6.83B$1.36B$4.55
2018-06-30$136.81B$7.18B$256.00M$0.82
2017-06-30$129.98B$6.54B$1.29B$4.06

Margins and returns by year

Period endGross marginNet marginReturn on equityReturn on capital
2026-06-303.84%0.67%-34.79%
2025-06-303.67%0.70%-29.58%
2024-06-303.27%0.38%-47.61%
2023-06-303.35%0.16%-24.08%
2022-06-303.58%-0.52%--12.33%
2021-06-304.17%0.38%37.65%5.66%
2020-06-304.49%-2.42%-206.25%-44.60%
2019-06-304.70%0.94%21.53%11.66%
2018-06-305.25%0.19%4.23%0.84%
2017-06-305.03%0.99%18.86%8.89%

Cash and debt by year

Period endCashDebt
2026-06-30$4.86B$7.00B
2025-06-30$3.87B$7.98B
2024-06-30$5.33B$4.66B
2023-06-30$4.08B$3.91B
2022-06-30$4.72B$4.74B
2021-06-30$3.41B$5.37B
2020-06-30$2.77B$6.76B
2019-06-30$2.53B$7.58B
2018-06-30$1.76B$8.01B
2017-06-30$6.94B$9.07B

Free cash flow by year

Period endFree cash flowStock-based compensation
2026-06-30$4.53B$367.00M
2025-06-30$1.85B$244.00M
2024-06-30$3.25B$121.00M
2023-06-30$2.36B$96.00M
2022-06-30$2.79B$81.00M
2021-06-30$2.03B$89.00M
2020-06-30$1.58B$90.00M
2019-06-30$2.39B$82.00M
2018-06-30$2.38B$85.00M
2017-06-30$797.00M$96.00M

Dividend history

Most recent payment
Oct 1, 2026
Paid in the last twelve months
$2.05
Payment dateDividend per share
2026-10-01$0.52
2026-07-01$0.52
2026-04-01$0.51
2026-01-02$0.51
2025-10-01$0.51
2025-07-01$0.51
2025-04-01$0.51
2025-01-02$0.51

Investor relations

Past earnings dates

ReportedFiscal periodEPS estimate
2026-11-05Sep 2026$2.92
2026-08-11Jun 2026$2.42
2026-04-30Mar 2026$2.80
2026-02-05Dec 2025$2.39
2025-10-30Sep 2025$2.21
2025-08-12Jun 2025$2.03
2025-05-01Mar 2025$2.15
2025-01-30Dec 2024$1.75

Filings and sources

Company website
cardinalhealth.com
SEC filings
10-K, 10-Q and 8-K on EDGAR
Earnings calendar
All upcoming reports

Similar companies

Henry Schein Inc (HSIC) · Cencora, Inc. (COR) · McKesson Corp (MCK) · UnitedHealth Group Inc (UNH) · CVS Health Corp (CVS) · Haleon plc (HLN) · Elevance Health, Inc. (ELV) · Hims & Hers Health, Inc. (HIMS)

All Healthcare companies

Understanding these figures

Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades